English
简体中文
Total: £ 56.28
Published Date: 2026-04-10 | Pages: 109 | Tables: 116 | Medical Devices & Consumables
The global Medical Endobronchial Blockers market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Medical Endobronchial Blockers competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Medical endobronchial blockers are devices used to occlude or block a specific bronchus within the lung during procedures requiring lung isolation. These blockers are inserted through the working channel of a bronchoscope and inflated to seal off the desired airway, allowing for selective ventilation or collapse of a lung during surgeries or treatments.
The North American market for Medical Endobronchial Blockers is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Medical Endobronchial Blockers is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Medical Endobronchial Blockers include Teleflex, Cook, Ambu, Daiken Medical, PROACT Medical, NexGen Medical, HangZhou Trifanz Medical Device, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Medical Endobronchial Blockers market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Medical Endobronchial Blockers. The Medical Endobronchial Blockers market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Medical Endobronchial Blockers market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Medical Endobronchial Blockers manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Teleflex
Cook
Ambu
Daiken Medical
PROACT Medical
NexGen Medical
HangZhou Trifanz Medical Device
Segment by Type
5 Fr
7 Fr
9 Fr
by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Medical Endobronchial Blockers manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Medical Endobronchial Blockers sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Medical Endobronchial Blockers Market Overview
1.1 Product Definition
1.2 Medical Endobronchial Blockers by Type
1.2.1 Global Medical Endobronchial Blockers Market Value by Type: 2025 vs 2032
1.2.2 5 Fr
1.2.3 7 Fr
1.2.4 9 Fr
1.3 Medical Endobronchial Blockers by Application
1.3.1 Global Medical Endobronchial Blockers Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Medical Endobronchial Blockers Market Size Estimates and Forecasts
1.4.1 Global Medical Endobronchial Blockers Revenue 2021–2032
1.4.2 Global Medical Endobronchial Blockers Sales 2021–2032
1.4.3 Global Medical Endobronchial Blockers Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Medical Endobronchial Blockers Market Competition by Manufacturers
2.1 Global Medical Endobronchial Blockers Sales Market Share by Manufacturers (2021–2026)
2.2 Global Medical Endobronchial Blockers Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Medical Endobronchial Blockers Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Medical Endobronchial Blockers, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Medical Endobronchial Blockers, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Medical Endobronchial Blockers, Product Types and Applications
2.7 Global Key Manufacturers of Medical Endobronchial Blockers, Date of Entry into the Industry
2.8 Global Medical Endobronchial Blockers Market Competitive Situation and Trends
2.8.1 Global Medical Endobronchial Blockers Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Medical Endobronchial Blockers Players Market Share by Revenue
2.8.3 Global Medical Endobronchial Blockers Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Medical Endobronchial Blockers Market Scenario by Region
3.1 Global Medical Endobronchial Blockers Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Medical Endobronchial Blockers Sales by Region: 2021–2032
3.2.1 Global Medical Endobronchial Blockers Sales by Region: 2021–2026
3.2.2 Global Medical Endobronchial Blockers Sales by Region: 2027–2032
3.3 Global Medical Endobronchial Blockers Revenue by Region: 2021–2032
3.3.1 Global Medical Endobronchial Blockers Revenue by Region: 2021–2026
3.3.2 Global Medical Endobronchial Blockers Revenue by Region: 2027–2032
3.4 North America Medical Endobronchial Blockers Market Facts & Figures by Country
3.4.1 North America Medical Endobronchial Blockers Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Medical Endobronchial Blockers Sales by Country (2021–2032)
3.4.3 North America Medical Endobronchial Blockers Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical Endobronchial Blockers Market Facts & Figures by Country
3.5.1 Europe Medical Endobronchial Blockers Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Medical Endobronchial Blockers Sales by Country (2021–2032)
3.5.3 Europe Medical Endobronchial Blockers Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Endobronchial Blockers Market Facts & Figures by Region
3.6.1 Asia Pacific Medical Endobronchial Blockers Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Medical Endobronchial Blockers Sales by Region (2021–2032)
3.6.3 Asia Pacific Medical Endobronchial Blockers Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Medical Endobronchial Blockers Market Facts & Figures by Country
3.7.1 Latin America Medical Endobronchial Blockers Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Medical Endobronchial Blockers Sales by Country (2021–2032)
3.7.3 Latin America Medical Endobronchial Blockers Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Medical Endobronchial Blockers Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Endobronchial Blockers Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Medical Endobronchial Blockers Sales by Country (2021–2032)
3.8.3 Middle East and Africa Medical Endobronchial Blockers Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Endobronchial Blockers Sales by Type (2021–2032)
4.1.1 Global Medical Endobronchial Blockers Sales by Type (2021–2026)
4.1.2 Global Medical Endobronchial Blockers Sales by Type (2027–2032)
4.1.3 Global Medical Endobronchial Blockers Sales Market Share by Type (2021–2032)
4.2 Global Medical Endobronchial Blockers Revenue by Type (2021–2032)
4.2.1 Global Medical Endobronchial Blockers Revenue by Type (2021–2026)
4.2.2 Global Medical Endobronchial Blockers Revenue by Type (2027–2032)
4.2.3 Global Medical Endobronchial Blockers Revenue Market Share by Type (2021–2032)
4.3 Global Medical Endobronchial Blockers Price by Type (2021–2032)
5 Segment by Application
5.1 Global Medical Endobronchial Blockers Sales by Application (2021–2032)
5.1.1 Global Medical Endobronchial Blockers Sales by Application (2021–2026)
5.1.2 Global Medical Endobronchial Blockers Sales by Application (2027–2032)
5.1.3 Global Medical Endobronchial Blockers Sales Market Share by Application (2021–2032)
5.2 Global Medical Endobronchial Blockers Revenue by Application (2021–2032)
5.2.1 Global Medical Endobronchial Blockers Revenue by Application (2021–2026)
5.2.2 Global Medical Endobronchial Blockers Revenue by Application (2027–2032)
5.2.3 Global Medical Endobronchial Blockers Revenue Market Share by Application (2021–2032)
5.3 Global Medical Endobronchial Blockers Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Teleflex
6.1.1 Teleflex Company Information
6.1.2 Teleflex Description and Business Overview
6.1.3 Teleflex Medical Endobronchial Blockers Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Teleflex Medical Endobronchial Blockers Product Portfolio
6.1.5 Teleflex Recent Developments/Updates
6.2 Cook
6.2.1 Cook Company Information
6.2.2 Cook Description and Business Overview
6.2.3 Cook Medical Endobronchial Blockers Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Cook Medical Endobronchial Blockers Product Portfolio
6.2.5 Cook Recent Developments/Updates
6.3 Ambu
6.3.1 Ambu Company Information
6.3.2 Ambu Description and Business Overview
6.3.3 Ambu Medical Endobronchial Blockers Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Ambu Medical Endobronchial Blockers Product Portfolio
6.3.5 Ambu Recent Developments/Updates
6.4 Daiken Medical
6.4.1 Daiken Medical Company Information
6.4.2 Daiken Medical Description and Business Overview
6.4.3 Daiken Medical Medical Endobronchial Blockers Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Daiken Medical Medical Endobronchial Blockers Product Portfolio
6.4.5 Daiken Medical Recent Developments/Updates
6.5 PROACT Medical
6.5.1 PROACT Medical Company Information
6.5.2 PROACT Medical Description and Business Overview
6.5.3 PROACT Medical Medical Endobronchial Blockers Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 PROACT Medical Medical Endobronchial Blockers Product Portfolio
6.5.5 PROACT Medical Recent Developments/Updates
6.6 NexGen Medical
6.6.1 NexGen Medical Company Information
6.6.2 NexGen Medical Description and Business Overview
6.6.3 NexGen Medical Medical Endobronchial Blockers Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 NexGen Medical Medical Endobronchial Blockers Product Portfolio
6.6.5 NexGen Medical Recent Developments/Updates
6.7 HangZhou Trifanz Medical Device
6.7.1 HangZhou Trifanz Medical Device Company Information
6.7.2 HangZhou Trifanz Medical Device Description and Business Overview
6.7.3 HangZhou Trifanz Medical Device Medical Endobronchial Blockers Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 HangZhou Trifanz Medical Device Medical Endobronchial Blockers Product Portfolio
6.7.5 HangZhou Trifanz Medical Device Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Endobronchial Blockers Industry Chain Analysis
7.2 Medical Endobronchial Blockers Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Endobronchial Blockers Production Mode & Process Analysis
7.4 Medical Endobronchial Blockers Sales and Marketing
7.4.1 Medical Endobronchial Blockers Sales Channels
7.4.2 Medical Endobronchial Blockers Distributors
7.5 Medical Endobronchial Blockers Customer Analysis
8 Medical Endobronchial Blockers Market Dynamics
8.1 Medical Endobronchial Blockers Industry Trends
8.2 Medical Endobronchial Blockers Market Drivers
8.3 Medical Endobronchial Blockers Market Challenges
8.4 Medical Endobronchial Blockers Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Medical Endobronchial Blockers Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Medical Endobronchial Blockers Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Medical Endobronchial Blockers Market Competitive Situation by Manufacturers in 2025
Table 4. Global Medical Endobronchial Blockers Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Medical Endobronchial Blockers Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Medical Endobronchial Blockers Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Medical Endobronchial Blockers Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Medical Endobronchial Blockers Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Medical Endobronchial Blockers, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Medical Endobronchial Blockers, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Medical Endobronchial Blockers, Product Types and Applications
Table 12. Global Key Manufacturers of Medical Endobronchial Blockers, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Medical Endobronchial Blockers Companies by Tier (Tier 1, Tier 2, Tier 3), based on Medical Endobronchial Blockers Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Medical Endobronchial Blockers Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Medical Endobronchial Blockers Sales by Region (K Units), 2021–2026
Table 18. Global Medical Endobronchial Blockers Sales Market Share by Region (2021–2026)
Table 19. Global Medical Endobronchial Blockers Sales by Region (K Units), 2027–2032
Table 20. Global Medical Endobronchial Blockers Sales Market Share by Region (2027–2032)
Table 21. Global Medical Endobronchial Blockers Revenue by Region (US$ Million), 2021–2026
Table 22. Global Medical Endobronchial Blockers Revenue Market Share by Region (2021–2026)
Table 23. Global Medical Endobronchial Blockers Revenue by Region (US$ Million), 2027–2032
Table 24. Global Medical Endobronchial Blockers Revenue Market Share by Region (2027–2032)
Table 25. North America Medical Endobronchial Blockers Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Medical Endobronchial Blockers Sales by Country (K Units), 2021–2026
Table 27. North America Medical Endobronchial Blockers Sales by Country (K Units), 2027–2032
Table 28. North America Medical Endobronchial Blockers Revenue by Country (US$ Million), 2021–2026
Table 29. North America Medical Endobronchial Blockers Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Medical Endobronchial Blockers Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Medical Endobronchial Blockers Sales by Country (K Units), 2021–2026
Table 32. Europe Medical Endobronchial Blockers Sales by Country (K Units), 2027–2032
Table 33. Europe Medical Endobronchial Blockers Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Medical Endobronchial Blockers Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Medical Endobronchial Blockers Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Medical Endobronchial Blockers Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Medical Endobronchial Blockers Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Medical Endobronchial Blockers Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Medical Endobronchial Blockers Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Medical Endobronchial Blockers Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Medical Endobronchial Blockers Sales by Country (K Units), 2021–2026
Table 42. Latin America Medical Endobronchial Blockers Sales by Country (K Units), 2027–2032
Table 43. Latin America Medical Endobronchial Blockers Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Medical Endobronchial Blockers Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Medical Endobronchial Blockers Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Medical Endobronchial Blockers Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Medical Endobronchial Blockers Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Medical Endobronchial Blockers Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Medical Endobronchial Blockers Revenue by Country (US$ Million), 2027–2032
Table 50. Global Medical Endobronchial Blockers Sales (K Units) by Type (2021–2026)
Table 51. Global Medical Endobronchial Blockers Sales (K Units) by Type (2027–2032)
Table 52. Global Medical Endobronchial Blockers Sales Market Share by Type (2021–2026)
Table 53. Global Medical Endobronchial Blockers Sales Market Share by Type (2027–2032)
Table 54. Global Medical Endobronchial Blockers Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Medical Endobronchial Blockers Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Medical Endobronchial Blockers Revenue Market Share by Type (2021–2026)
Table 57. Global Medical Endobronchial Blockers Revenue Market Share by Type (2027–2032)
Table 58. Global Medical Endobronchial Blockers Price (US$/Unit) by Type (2021–2026)
Table 59. Global Medical Endobronchial Blockers Price (US$/Unit) by Type (2027–2032)
Table 60. Global Medical Endobronchial Blockers Sales (K Units) by Application (2021–2026)
Table 61. Global Medical Endobronchial Blockers Sales (K Units) by Application (2027–2032)
Table 62. Global Medical Endobronchial Blockers Sales Market Share by Application (2021–2026)
Table 63. Global Medical Endobronchial Blockers Sales Market Share by Application (2027–2032)
Table 64. Global Medical Endobronchial Blockers Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Medical Endobronchial Blockers Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Medical Endobronchial Blockers Revenue Market Share by Application (2021–2026)
Table 67. Global Medical Endobronchial Blockers Revenue Market Share by Application (2027–2032)
Table 68. Global Medical Endobronchial Blockers Price (US$/Unit) by Application (2021–2026)
Table 69. Global Medical Endobronchial Blockers Price (US$/Unit) by Application (2027–2032)
Table 70. Teleflex Company Information
Table 71. Teleflex Description and Business Overview
Table 72. Teleflex Medical Endobronchial Blockers Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Teleflex Medical Endobronchial Blockers Product
Table 74. Teleflex Recent Developments/Updates
Table 75. Cook Company Information
Table 76. Cook Description and Business Overview
Table 77. Cook Medical Endobronchial Blockers Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Cook Medical Endobronchial Blockers Product
Table 79. Cook Recent Developments/Updates
Table 80. Ambu Company Information
Table 81. Ambu Description and Business Overview
Table 82. Ambu Medical Endobronchial Blockers Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Ambu Medical Endobronchial Blockers Product
Table 84. Ambu Recent Developments/Updates
Table 85. Daiken Medical Company Information
Table 86. Daiken Medical Description and Business Overview
Table 87. Daiken Medical Medical Endobronchial Blockers Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Daiken Medical Medical Endobronchial Blockers Product
Table 89. Daiken Medical Recent Developments/Updates
Table 90. PROACT Medical Company Information
Table 91. PROACT Medical Description and Business Overview
Table 92. PROACT Medical Medical Endobronchial Blockers Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. PROACT Medical Medical Endobronchial Blockers Product
Table 94. PROACT Medical Recent Developments/Updates
Table 95. NexGen Medical Company Information
Table 96. NexGen Medical Description and Business Overview
Table 97. NexGen Medical Medical Endobronchial Blockers Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. NexGen Medical Medical Endobronchial Blockers Product
Table 99. NexGen Medical Recent Developments/Updates
Table 100. HangZhou Trifanz Medical Device Company Information
Table 101. HangZhou Trifanz Medical Device Description and Business Overview
Table 102. HangZhou Trifanz Medical Device Medical Endobronchial Blockers Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. HangZhou Trifanz Medical Device Medical Endobronchial Blockers Product
Table 104. HangZhou Trifanz Medical Device Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Medical Endobronchial Blockers Distributors List
Table 108. Medical Endobronchial Blockers Customers List
Table 109. Medical Endobronchial Blockers Market Trends
Table 110. Medical Endobronchial Blockers Market Drivers
Table 111. Medical Endobronchial Blockers Market Challenges
Table 112. Medical Endobronchial Blockers Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Medical Endobronchial Blockers
Figure 2. Global Medical Endobronchial Blockers Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Medical Endobronchial Blockers Market Share by Type: 2025 & 2032
Figure 4. 5 Fr Product Picture
Figure 5. 7 Fr Product Picture
Figure 6. 9 Fr Product Picture
Figure 7. Global Medical Endobronchial Blockers Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Medical Endobronchial Blockers Market Share by Application: 2025 & 2032
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Medical Endobronchial Blockers Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Medical Endobronchial Blockers Market Size (US$ Million), 2021–2032
Figure 14. Global Medical Endobronchial Blockers Sales (K Units), 2021–2032
Figure 15. Global Medical Endobronchial Blockers Average Price (US$/Unit), 2021–2032
Figure 16. Medical Endobronchial Blockers Report Years Considered
Figure 17. Medical Endobronchial Blockers Sales Share by Manufacturers in 2025
Figure 18. Global Medical Endobronchial Blockers Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Medical Endobronchial Blockers Players: Market Share by Revenue in Medical Endobronchial Blockers in 2025
Figure 20. Medical Endobronchial Blockers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Medical Endobronchial Blockers Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Medical Endobronchial Blockers Sales Market Share by Country (2021–2032)
Figure 23. North America Medical Endobronchial Blockers Revenue Market Share by Country (2021–2032)
Figure 24. United States Medical Endobronchial Blockers Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Medical Endobronchial Blockers Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Medical Endobronchial Blockers Sales Market Share by Country (2021–2032)
Figure 27. Europe Medical Endobronchial Blockers Revenue Market Share by Country (2021–2032)
Figure 28. Germany Medical Endobronchial Blockers Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Medical Endobronchial Blockers Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Medical Endobronchial Blockers Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Medical Endobronchial Blockers Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Medical Endobronchial Blockers Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Medical Endobronchial Blockers Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Medical Endobronchial Blockers Revenue Market Share by Region (2021–2032)
Figure 35. China Medical Endobronchial Blockers Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Medical Endobronchial Blockers Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Medical Endobronchial Blockers Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Medical Endobronchial Blockers Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Medical Endobronchial Blockers Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Medical Endobronchial Blockers Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Medical Endobronchial Blockers Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Medical Endobronchial Blockers Sales Market Share by Country (2021–2032)
Figure 43. Latin America Medical Endobronchial Blockers Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Medical Endobronchial Blockers Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Medical Endobronchial Blockers Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Medical Endobronchial Blockers Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Medical Endobronchial Blockers Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Medical Endobronchial Blockers Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Medical Endobronchial Blockers Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Medical Endobronchial Blockers Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Medical Endobronchial Blockers Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Medical Endobronchial Blockers Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Medical Endobronchial Blockers by Type (2021–2032)
Figure 54. Global Revenue Market Share of Medical Endobronchial Blockers by Type (2021–2032)
Figure 55. Global Medical Endobronchial Blockers Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Medical Endobronchial Blockers by Application (2021–2032)
Figure 57. Global Revenue Market Share of Medical Endobronchial Blockers by Application (2021–2032)
Figure 58. Global Medical Endobronchial Blockers Price (US$/Unit) by Application (2021–2032)
Figure 59. Medical Endobronchial Blockers Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
